| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.9M | +3.8% |
| Cost of Revenue | $3.9M | +2.5% |
| Gross Profit | $5.0M | +4.8% |
| R&D Expense | $5.4M | +24.9% |
| SG&A Expense | $17.2M | -2.2% |
| Operating Income | -$17.6M | -2.7% |
| Pre-tax Income | -$20.2M | -39.2% |
| Income Tax | $8K | -11.1% |
| Net Income | -$20.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | -78.6% |
| Accounts Receivable | $2.0M | +38.8% |
| Inventory | $2.0M | -25.0% |
| Current Assets | $8.2M | -63.9% |
| Total Assets | $9.8M | -60.4% |
| Current Liabilities | $3.2M | -32.3% |
| Total Liabilities | $6.6M | -46.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.9M | -18.4% |
| Capital Expenditures | $149K | +22.1% |
| Investing Cash Flow | $330K | -97.8% |
| Financing Cash Flow | $3.7M | -60.9% |
| Free Cash Flow | -$18.1M | -18.4% |
| -39.1% |
| EPS (Basic) | -$11.52 | +86.2% |
| EPS (Diluted) | -$11.52 | +86.2% |
| Stockholders' Equity |
| $3.0M |
| -75.8% |